1. Home
  2. NVEC vs OMER Comparison

NVEC vs OMER Comparison

Compare NVEC & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVEC
  • OMER
  • Stock Information
  • Founded
  • NVEC 1989
  • OMER 1994
  • Country
  • NVEC United States
  • OMER United States
  • Employees
  • NVEC N/A
  • OMER N/A
  • Industry
  • NVEC Semiconductors
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVEC Technology
  • OMER Health Care
  • Exchange
  • NVEC Nasdaq
  • OMER Nasdaq
  • Market Cap
  • NVEC 373.9M
  • OMER 391.1M
  • IPO Year
  • NVEC 1996
  • OMER 2009
  • Fundamental
  • Price
  • NVEC $78.42
  • OMER $7.73
  • Analyst Decision
  • NVEC
  • OMER Buy
  • Analyst Count
  • NVEC 0
  • OMER 3
  • Target Price
  • NVEC N/A
  • OMER $9.00
  • AVG Volume (30 Days)
  • NVEC 14.7K
  • OMER 1.2M
  • Earning Date
  • NVEC 01-15-2025
  • OMER 11-13-2024
  • Dividend Yield
  • NVEC 5.12%
  • OMER N/A
  • EPS Growth
  • NVEC N/A
  • OMER N/A
  • EPS
  • NVEC 3.33
  • OMER N/A
  • Revenue
  • NVEC $27,381,423.00
  • OMER N/A
  • Revenue This Year
  • NVEC N/A
  • OMER N/A
  • Revenue Next Year
  • NVEC N/A
  • OMER N/A
  • P/E Ratio
  • NVEC $22.70
  • OMER N/A
  • Revenue Growth
  • NVEC N/A
  • OMER N/A
  • 52 Week Low
  • NVEC $69.73
  • OMER $1.81
  • 52 Week High
  • NVEC $90.24
  • OMER $7.51
  • Technical
  • Relative Strength Index (RSI)
  • NVEC 52.07
  • OMER 77.09
  • Support Level
  • NVEC $74.12
  • OMER $5.55
  • Resistance Level
  • NVEC $76.23
  • OMER $7.51
  • Average True Range (ATR)
  • NVEC 2.28
  • OMER 0.64
  • MACD
  • NVEC -0.18
  • OMER 0.27
  • Stochastic Oscillator
  • NVEC 50.20
  • OMER 96.88

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: